Adare Pharma Solutions has a variety of monograph softgel product formulation profiles that it can efficiently manufacture right away
To ensure compliance, a drug evaluation monograph is required that scientifically documents critical information such as ingredients, drug class, and instructions for usage. Adare has developed strategic competencies with prior authorization drugs.
Whether you need a custom product or an OTC monograph softgel, Adare Pharma Solutions has the technology and flexibility to quickly deliver scalability to fit your organization’s needs. If you’re interested in bringing a monograph product to market quickly, please request our list of formulations from our commercialization expert.
Speak With An Expert
Giuseppe Di Vincenzo
Chief Strategy Officer
Giuseppe leads our strategy, communications and internal pipeline development teams.
He was previously Vice President, Strategic and Commercial Development at Adare where he was responsible for commercial strategy, marketing, business development and internal pipeline development activities. Prior to that, he was Vice President Global Sales and Strategy at Aptalis Pharmaceutical Technologies. Before joining Aptalis, he held a number of senior positions at Eurand. He also held roles with Élan Corporation and Arthur D. Little.
Giuseppe holds a degree in Biology from the University Federico II of Naples, Italy and a Master of Business Administration from the London Business School, United Kingdom.
